Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.
Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores
Kei Amemiya
Until recently, the vaccine against Yersinia pestis, the etiological agent of plague, consisted of a formalin-inactivated,
whole-cell vaccine. The vaccine was discontinued because it apparently only protected the vaccinated host against
bubonic plague but not pneumonic plague. We have since found that the whole-cell vaccine only induced antibodies
against the capsule F1 protein but not antibodies against the virulence protein (V-antigen) that appears to be required
for a robust protection. The new plague vaccine consists of subunits of the F1 capsule protein and V-antigen either as
individual subunits or a fusion of the two subunits. The genes for each these proteins are encoded on two separate
virulence plasmids; one of the plasmids is specific for Y. pestis.